| Schedule of net income (loss) per share |
| | For the three months ended March 31, 2026 | | | For the three months ended March 31, 2025 | | | | | | | | | Net (loss) income | | $ | (29,122 | ) | | $ | 472,592 | | Accretion of carrying value to redemption value | | | (435,783 | ) | | | (726,071 | ) | Net loss including accretion of carrying value of redemption value | | $ | (464,905 | ) | | $ | (253,479 | ) |
| | For the Three Months Ended | | | | March 31, 2026 | | | | | | | Non- | | | | Redeemable | | | Redeemable | | | | Common | | | Common | | | | Stock | | | Stock | | Basic and diluted net income (loss) per share: | | | | | | | Numerators: | | | | | | | Allocation of net loss including carrying value to redemption value | | $ | (328,583 | ) | | $ | (136,222 | ) | Net loss attributable to ordinary shares subject to redemption | | | 12,675 | | | | | | Accretion of carrying value to redemption value | | | 435,783 | | | | - | | Allocation of net income (loss) | | $ | 119,875 | | | $ | (136,222 | ) | | | | | | | | | | Denominators: | | | | | | | | | Weighted-average shares outstanding | | | 1,752,170 | | | | 2,180,000 | | Basic and diluted net income (loss) per share | | $ | 0.07 | | | $ | (0.06 | ) |
| | For the Three Months Ended | | | | March 31, 2025 | | | | | | | Non- | | | | Redeemable | | | Redeemable | | | | Common | | | Common | | | | Stock | | | Stock | | Basic and diluted net income (loss) per share: | | | | | | | Numerators: | | | | | | | Allocation of net loss including carrying value to redemption value | | $ | (192,622 | ) | | $ | (60,857 | ) | Accretion of carrying value to redemption value | | | 726,071 | | | | - | | Allocation of net income (loss) | | $ | 533,449 | | | $ | (60,857 | ) | | | | | | | | | | Denominators: | | | | | | | | | Weighted-average shares outstanding | | | 6,900,000 | | | | 2,180,000 | | Basic and diluted net income (loss) per share | | $ | 0.08 | | | $ | (0.03 | ) |
|